Allergic nasolacrimal obstruction. Case report.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001414:Bacitracin / Q000008:administration & dosage / Q000009:adverse effects; D001762:Blepharitis / Q000139:chemically induced; D003233:Conjunctivitis, Allergic / Q000139:chemically induced; D004338:Drug Combinations / Q000008:administration & dosage / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000473:pathology; D006096:Gramicidin / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D006968:Hypersensitivity, Delayed; D007767:Lacrimal Duct Obstruction / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D009301:Nasolacrimal Duct; D009355:Neomycin / Q000008:administration & dosage / Q000009:adverse effects; D009824:Ointments; D009883:Ophthalmic Solutions; D011112:Polymyxin B / Q000008:administration & dosage / Q000009:adverse effects; D011113:Polymyxins / Q000008:administration & dosage / Q000009:adverse effects; D012220:Rhinitis / Q000139:chemically induced
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D009824:Ointments; D009883:Ophthalmic Solutions; D011113:Polymyxins; D001414:Bacitracin; D006096:Gramicidin; C001816:bacitracin zinc, neomycin sulfate, polymyxin B, drug combination; D009355:Neomycin; D011112:Polymyxin B